Receptors, Serotonin, 5-HT3
This graph shows the total number of publications written about "Receptors, Serotonin, 5-HT3" by people in the URMC Research Network by year, and whether "Receptors, Serotonin, 5-HT3" was a major or minor topic of these publication.
Below are the most recent publications written about "Receptors, Serotonin, 5-HT3" by people in Profiles.
-
Hickok JT, Roscoe JA, Morrow GR, Bole CW, Zhao H, Hoelzer KL, Dakhil SR, Moore T, Fitch TR. 5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol. 2005 Oct; 6(10):765-72.
-
Hickok JT, Roscoe JA, Morrow GR, King DK, Atkins JN, Fitch TR. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer. 2003 Jun 1; 97(11):2880-6.
-
Morrow GR, Roscoe JA, Kirshner JJ, Hynes HE, Rosenbluth RJ. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Support Care Cancer. 1998 May; 6(3):244-7.
